Fig. 1From: The COVID-19 pandemic as a catalyst for innovation: a regulatory framework to assess fit-for-purpose innovative approaches in clinical researchExamples of innovative approaches considered during the pandemic. IMP, investigational medicinal product; PI, principal investigatorBack to article page